| Title |
Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9
|
|---|---|
| Published in |
BioDrugs, November 2019
|
| DOI | 10.1007/s40259-019-00399-6 |
| Pubmed ID | |
| Authors |
Charles A. German, Michael D. Shapiro |
X Demographics
The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 9 | 36% |
| United States | 2 | 8% |
| Denmark | 1 | 4% |
| Comoros | 1 | 4% |
| Venezuela, Bolivarian Republic of | 1 | 4% |
| Mexico | 1 | 4% |
| Unknown | 10 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 19 | 76% |
| Practitioners (doctors, other healthcare professionals) | 4 | 16% |
| Scientists | 1 | 4% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 97 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 16 | 16% |
| Student > Master | 10 | 10% |
| Researcher | 9 | 9% |
| Student > Ph. D. Student | 5 | 5% |
| Other | 4 | 4% |
| Other | 10 | 10% |
| Unknown | 43 | 44% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 14 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 9% |
| Biochemistry, Genetics and Molecular Biology | 8 | 8% |
| Chemistry | 4 | 4% |
| Agricultural and Biological Sciences | 2 | 2% |
| Other | 11 | 11% |
| Unknown | 49 | 51% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 July 2023.
All research outputs
#1,768,408
of 25,732,188 outputs
Outputs from BioDrugs
#33
of 756 outputs
Outputs of similar age
#41,841
of 480,166 outputs
Outputs of similar age from BioDrugs
#3
of 7 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 756 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.5. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 480,166 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.